EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Update on the genetics of paragangliomas

Anne-Paule Gimenez-Roqueplo, Mercedes Robledo iD, Patricia L M Dahia iD

Endocrine-Related Cancer · 07.02.2023 · 30 (4)

DOI: 10.1530/erc-22-0373 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine-Related Cancer, erschienen am 07.02.2023. Verfasst von Anne-Paule Gimenez-Roqueplo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Université Paris Cité, PARCC, INSERM, Paris, France. Hauptthemen laut MEDLINE: Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Paragangliomas (PGL) of the adrenal (also known as pheochromocytomas) or extra-adrenal neural crest-derived cells are highly heritable tumors, usually driven by single pathogenic variants that occur mutually exclusively in genes involved in multiple cellular processes, including the response to hypoxia, MAPK/ERK signaling, and WNT signaling. The discovery of driver mutations has led to active clinical surveillance with outcome implications in familial PGL. The spectrum of mutations continues to grow and reveal unique mechanisms of tumorigenesis that inform tumor biology and provide the rationale for targeted therapy. Here we review recent progress in the genetics and molecular pathogenesis of PGLs and discuss new prospects for advancing research with new disease models and ongoing clinical trials presented at the recent International Symposium of Pheochromocytomas and Paragangliomas (ISP2022) held in October 2022 in Prague.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaParagangliomaAdrenal Gland NeoplasmsHumansMutation

Stichwörter der Autor:innen

germline mutationsparagangliomapheochromocytomasomatic mutationssusceptibility genes

Autor:innen und Institutionen

  • Université Paris Cité, PARCC, INSERM, Paris, France.
  • Département de Médecine Génomique des Tumeurs et des Cancers, Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
  • Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Biomedical Research Networking Centre on Rare Diseases (CIBERER), Institute of Health Carlos III, Madrid, Spain.
  • Division of Hematology and Medical Oncology, Department Medicine, University of Texas Health Science Center at San Antonio (UTHSCSA), San Antonio, Texas, USA.
  • Mays Cancer Center at UTHSCSA, San Antonio, Texas, USA.

ORCID-Profile: Mercedes Robledo, Patricia L M Dahia

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Gimenez-Roqueplo, A. P., Robledo, M., & Dahia, P. L. M. (2023). Update on the genetics of paragangliomas. Endocrine-Related Cancer, 30(4). https://doi.org/10.1530/erc-22-0373

Vancouver

Gimenez-Roqueplo AP, Robledo M, Dahia PLM. Update on the genetics of paragangliomas. Endocrine-Related Cancer. 2023;30(4). doi:10.1530/erc-22-0373

BibTeX
@article{GimenezRoqueplo2023,
  author = {Gimenez-Roqueplo, Anne-Paule and Robledo, Mercedes and Dahia, Patricia L M},
  title = {Update on the genetics of paragangliomas},
  journal = {Endocrine-Related Cancer},
  year = {2023},
  volume = {30},
  number = {4},
  doi = {10.1530/erc-22-0373}
}
Kostenlos starten →